Thank you for your statement, Cabinet Secretary. As I said when you unveiled it, the new treatment fund is a most welcome addition to the NHS as it can speed up access to vital treatments for all patients, and not simply people suffering with a cancer diagnosis. I welcome the news that some medicines have taken just 17 days to become available under the new treatment fund, and this is wonderful news for patients. However, as with all such schemes, the devil is in the detail. Delivery never quite matches design. Not all local health boards are as efficient in introducing new treatments, and I welcome the steps you have taken to monitor compliance. Cabinet Secretary, can you update us on the how all the local health boards are complying with the requirement to make treatments available within the required timescales?

I welcome the fact that 82 new drugs have now been made available under the scheme, treating everything from arthritis to acromegaly. I must confess I had to look up that condition, but it is great news that people who suffer from this debilitating hormonal disorder can now get treatment in Wales. This highlights the massive improvement the new treatment fund is on the cancer drugs fund in England. This scheme can benefit all patients in Wales, as well as those suffering from cancer. I would be grateful, Cabinet Secretary, if you could outline how many patients have benefitted from the fund in the last 12 months.

Of course, the new treatment fund only supports the introduction of new treatments for the first 12 months. Health boards must accommodate ongoing treatment within their existing budgets. So Cabinet Secretary, can you update us on how health boards are planning to accommodate the additional expenditure of these new treatments during the coming financial year?

I also welcome the news that your Government continues to work with the pharmaceutical industry and that you are working with ABPI Cymru on the new treatment fund. I would be grateful, Cabinet Secretary, if you could outline the work being undertaken to improve horizon scanning within the NHS so that we are better prepared to maximise the benefits of future treatments.

Finally, Cabinet Secretary, this is a treatments fund, and while I greatly welcome 82 new medicines, the fund is not limited to pharmaceutical interventions. So, can we look forward to the fund being used to introduce new therapeutic interventions in the next 12 months?

I welcome your statement, Cabinet Secretary, and the news that patients in Wales can get early access to better treatments, sometimes just days after approval. I look forward to working with you over the next 12 months to ensure that these new treatments are available to every patient who needs them, regardless of where they live in Wales. Diolch yn fawr.